H-1B sponsorship profile: Immunomic Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Immunomic Therapeutics, Inc filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Immunomic Therapeutics, Inc’s H-1B petitions range from $166,860 at the low end to $175,866 at the high end, with a petition-weighted average of $171,363. That range reflects the mix of occupations the company sponsors, led by Director, Financial Planning and Analysis (2 petitions at $171,363 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Immunomic Therapeutics, Inc is headquartered in Rockville, MD under NAICS code 541714, and places H-1B workers across 1 state, most heavily in MD. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Immunomic Therapeutics, Inc ranks. By H-1B petition volume, Immunomic Therapeutics, Inc is #48,558 of 119,880 employers nationally and #853 of 2,045 employers headquartered in MD. Both ranks are computed live from the same underlying petition counts, not a separate estimate.